(Q36180442)

12 August 2017

The NFTI-QOL: A Disease-Specific Quality of Life Questionnaire for Neurofibromatosis 2. (English)

1 reference

12 August 2017

1 reference

1 reference

Rachael E Hornigold

1

1 reference

12 August 2017

John F Golding

2

1 reference

12 August 2017

Guy Leschziner

3

1 reference

12 August 2017

Rupert Obholzer

4

1 reference

12 August 2017

Michael J Gleeson

5

1 reference

12 August 2017

Nick Thomas

6

1 reference

12 August 2017

Daniel Walsh

7

1 reference

12 August 2017

Shakeel Saeed

8

1 reference

12 August 2017

Rosalie E Ferner

9

1 reference

12 August 2017

1 April 2012

1 reference

Journal of neurological surgery. Part B, Skull base

12 August 2017

1 reference

12 August 2017

73

1 reference

12 August 2017

2

1 reference

12 August 2017

104-111

1 reference

Bevacizumab induces regression of vestibular schwannomas in patients with neurofibromatosis type 2

12 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3424623

The social impact of dizziness in London and Siena

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3424623

Hearing improvement after bevacizumab in patients with neurofibromatosis type 2

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3424623

Dissecting and targeting the growth factor-dependent and growth factor-independent extracellular signal-regulated kinase pathway in human schwannoma

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3424623

Neurofibromatosis 1 and neurofibromatosis 2: a twenty first century perspective.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3424623

EuroQol--a new facility for the measurement of health-related quality of life

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3424623

Variations in population health status: results from a United Kingdom national questionnaire survey

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3424623

A qualitative study of the impact of living with neurofibromatosis type 2.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3424623

The relationship between patients' perception of the effects of neurofibromatosis type 2 and the domains of the Short Form-36.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3424623

Birth incidence and prevalence of tumor-prone syndromes: Estimates from a UK family genetic register service

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3424623

What's new in neurofibromatosis? Proceedings from the 2009 NF Conference: new frontiers

21 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3424623

Evaluation of clinical diagnostic criteria for neurofibromatosis 2

21 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23543835

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1055/S-0032-1301396

1 reference

12 August 2017

1 reference

12 August 2017

1 reference